In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
LSU prof Naohiro Kato creates okra seed Mardi Gras beads
In New Orleans, Louisiana State University Associate Professor Naohiro Kato has created an updated version of his biobased Mardis Gras beads that contain okra...
Amazon, IIT Roorkee trial mailers made from India’s ag waste
In India, e-commerce giant Amazon has partnered with the Indian Institute of Technology Roorkee in a 15-month pilot project to convert agricultural waste into...
Sony creates materials consortium to find bioplastics suitable for electronics
In Tokyo, Sony Corporation is leading a large consortium of materials manufacturers to create a supply chain for biobased plastics that can be used...